Skip to main content
Top
Published in: neurogenetics 3/2005

01-09-2005 | Review Article

Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses

Authors: Sara E. Mole, Ruth E. Williams, Hans H. Goebel

Published in: Neurogenetics | Issue 3/2005

Login to get access

Abstract

The neuronal ceroid lipofuscinoses (NCLs) are a group of severe neurodegenerative diseases with onset usually in childhood and characterised by the intracellular accumulation of autofluorescent storage material. Within the last decade, mutations that cause NCL have been found in six human genes (CLN1, CLN2, CLN3, CLN5, CLN6 and CLN8). Mutations in two additional genes cause disease in animal models that share features with NCL-CTSD in sheep and mice and PPT2 in mice. Approximately 160 NCL disease-causing mutations have now been described (listed and fully cited in the NCL Mutation Database, http://​www.​ucl.​ac.​uk/​ncl/​). Most mutations result in a classic morphology and disease phenotype, but some mutations are associated with disease that is of later onset, less severe or protracted in its course, or with atypical morphology. Seven common mutations exist, some having a worldwide distribution and others associated with families originating from specific geographical regions. This review attempts to correlate the gene, disease-causing mutation, morphology and clinical phenotype for each type of NCL.
Literature
1.
go back to reference Santavuori P (1988) Neuronal ceroid lipofuscinosis in childhood. Brain Dev 10:80–83PubMed Santavuori P (1988) Neuronal ceroid lipofuscinosis in childhood. Brain Dev 10:80–83PubMed
2.
go back to reference Goebel HH, Mole SE, Lake BD (eds) (1999) The neuronal ceroid lipofuscinoses (Batten disease). Biomedical and health research. IOS, Amsterdam, pp 211 Goebel HH, Mole SE, Lake BD (eds) (1999) The neuronal ceroid lipofuscinoses (Batten disease). Biomedical and health research. IOS, Amsterdam, pp 211
3.
go back to reference Mole SE (2004) The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol 14:70–76PubMedCrossRef Mole SE (2004) The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol 14:70–76PubMedCrossRef
5.
go back to reference Zeman W (1970) Historical development of the nosological concept of amaurotic familial idiocy. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol. 10. North-Holland, Amsterdam, pp 212–232 Zeman W (1970) Historical development of the nosological concept of amaurotic familial idiocy. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol. 10. North-Holland, Amsterdam, pp 212–232
7.
go back to reference Goebel HH (2000) The new nosography of the neuronal ceroid-lipofuscinoses. Ann Pathol 20:479–491PubMed Goebel HH (2000) The new nosography of the neuronal ceroid-lipofuscinoses. Ann Pathol 20:479–491PubMed
8.
go back to reference Goebel HH, Wisniewski KE (2004) Current state of clinical and morphological features in human NCL. Brain Pathol 14:61–69PubMedCrossRef Goebel HH, Wisniewski KE (2004) Current state of clinical and morphological features in human NCL. Brain Pathol 14:61–69PubMedCrossRef
9.
go back to reference Tyynelä J, Baumann M, Henseler M, Sandhoff K, Haltia M (1995) Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study. Acta Neuropathol 89:391–398PubMed Tyynelä J, Baumann M, Henseler M, Sandhoff K, Haltia M (1995) Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study. Acta Neuropathol 89:391–398PubMed
10.
go back to reference Tyynelä J, Suopanki J, Baumann M, Haltia M (1997) Sphingolipid activator proteins (SAPs) in neuronal ceroid-lipofuscinoses (NCL). Neuropediatrics 28:49–52PubMed Tyynelä J, Suopanki J, Baumann M, Haltia M (1997) Sphingolipid activator proteins (SAPs) in neuronal ceroid-lipofuscinoses (NCL). Neuropediatrics 28:49–52PubMed
11.
go back to reference Tyynelä J, Palmer DN, Baumann M, Haltia M (1993) Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett 330:8–12CrossRefPubMed Tyynelä J, Palmer DN, Baumann M, Haltia M (1993) Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett 330:8–12CrossRefPubMed
12.
go back to reference Elleder M, Sokolova J, Hrebicek M (1997) Follow-up study of subunit c of mitochondrial ATP synthase (ASCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol 93:379–390CrossRefPubMed Elleder M, Sokolova J, Hrebicek M (1997) Follow-up study of subunit c of mitochondrial ATP synthase (ASCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol 93:379–390CrossRefPubMed
13.
go back to reference Palmer DN, Martinus RD, Cooper SM, Midwinter GG, Reid JC, Jolly RD (1989) Ovine ceroid lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem 264:5736–5740PubMed Palmer DN, Martinus RD, Cooper SM, Midwinter GG, Reid JC, Jolly RD (1989) Ovine ceroid lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem 264:5736–5740PubMed
14.
go back to reference Palmer DN, Fearnley IM, Walker JE, Hall NA, Lake BD, Wolfe LS, Haltia M, Martinus RD, Jolly RD (1992) Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 42:561–567CrossRefPubMed Palmer DN, Fearnley IM, Walker JE, Hall NA, Lake BD, Wolfe LS, Haltia M, Martinus RD, Jolly RD (1992) Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 42:561–567CrossRefPubMed
15.
go back to reference Eiberg H, Gardiner RM, Mohr J (1989) Batten disease (Spielmeyer–Sjögren disease) and haptoglobins (HP): indication of linkage and assignment to chromosome 16. Clin Genet 36:217–218PubMedCrossRef Eiberg H, Gardiner RM, Mohr J (1989) Batten disease (Spielmeyer–Sjögren disease) and haptoglobins (HP): indication of linkage and assignment to chromosome 16. Clin Genet 36:217–218PubMedCrossRef
16.
go back to reference Zeman W, Rider JA (eds) (1975) The dissection of a degenerative disease. Elsevier, New York Zeman W, Rider JA (eds) (1975) The dissection of a degenerative disease. Elsevier, New York
17.
go back to reference Wisniewski KE, Kida E, Golabek A, Kaczmarski W, Connell F, Zhong N (2001) Neuronal ceroid lipofuscinoses: classification and diagnosis. In: Wisniewski KE, Zhong N (eds) Batten disease: diagnosis, treatment, and research. Academic, San Diego, pp 1–34 Wisniewski KE, Kida E, Golabek A, Kaczmarski W, Connell F, Zhong N (2001) Neuronal ceroid lipofuscinoses: classification and diagnosis. In: Wisniewski KE, Zhong N (eds) Batten disease: diagnosis, treatment, and research. Academic, San Diego, pp 1–34
18.
go back to reference Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L (1996) Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J 15:5240–5245PubMed Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L (1996) Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J 15:5240–5245PubMed
19.
go back to reference Verkruyse LA, Hofmann SL (1996) Lysosomal targeting of palmitoyl-protein thioesterase. J Biol Chem 271:15831–15836CrossRefPubMed Verkruyse LA, Hofmann SL (1996) Lysosomal targeting of palmitoyl-protein thioesterase. J Biol Chem 271:15831–15836CrossRefPubMed
20.
go back to reference Ahtiainen L, Van Diggelen OP, Jalanko A, Kopra O (2003) Palmitoyl protein thioesterase 1 is targeted to the axons in neurons. J Comp Neurol 455:368–377CrossRefPubMed Ahtiainen L, Van Diggelen OP, Jalanko A, Kopra O (2003) Palmitoyl protein thioesterase 1 is targeted to the axons in neurons. J Comp Neurol 455:368–377CrossRefPubMed
21.
go back to reference Camp LA, Hofmann SL (1993) Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J Biol Chem 268:22566–22574PubMed Camp LA, Hofmann SL (1993) Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J Biol Chem 268:22566–22574PubMed
22.
go back to reference Camp LA, Verkruyse LA, Afendis SJ, Slaughter CA, Hofmann SL (1994) Molecular cloning and expression of palmitoyl-protein thioesterase. J Biol Chem 269:23212–23219PubMed Camp LA, Verkruyse LA, Afendis SJ, Slaughter CA, Hofmann SL (1994) Molecular cloning and expression of palmitoyl-protein thioesterase. J Biol Chem 269:23212–23219PubMed
23.
go back to reference Chattopadhyay S, Pearce DA (2000) Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3. Mol Genet Metab 71:207–211CrossRefPubMed Chattopadhyay S, Pearce DA (2000) Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3. Mol Genet Metab 71:207–211CrossRefPubMed
24.
go back to reference Heinonen O, Salonen T, Jalanko A, Peltonen L, Copp A (2000) CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain. J Comp Neurol 426:406–412CrossRefPubMed Heinonen O, Salonen T, Jalanko A, Peltonen L, Copp A (2000) CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain. J Comp Neurol 426:406–412CrossRefPubMed
25.
go back to reference Bellizzi JJ III, Widom J, Kemp C, Lu JY, Das AK, Hofmann SL, Clardy J (2000) The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. Proc Natl Acad Sci U S A 97:4573–4578CrossRefPubMed Bellizzi JJ III, Widom J, Kemp C, Lu JY, Das AK, Hofmann SL, Clardy J (2000) The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. Proc Natl Acad Sci U S A 97:4573–4578CrossRefPubMed
26.
go back to reference van Diggelen OP, Keulemans JL, Winchester B, Hofman IL, Vanhanen SL, Santavuori P, Voznyi YV (1999) A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL. Mol Genet Metab 66:240–244CrossRefPubMed van Diggelen OP, Keulemans JL, Winchester B, Hofman IL, Vanhanen SL, Santavuori P, Voznyi YV (1999) A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL. Mol Genet Metab 66:240–244CrossRefPubMed
27.
go back to reference Voznyi YV, Keulemans JL, Mancini GM, Catsman-Berrevoets CE, Young E, Winchester B, Kleijer WJ, van Diggelen OP (1999) A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J Med Genet 36:471–474PubMed Voznyi YV, Keulemans JL, Mancini GM, Catsman-Berrevoets CE, Young E, Winchester B, Kleijer WJ, van Diggelen OP (1999) A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J Med Genet 36:471–474PubMed
28.
go back to reference Halac IN, Kramer RD, Kohan R, Tapia V, Guelbert N, Oller-Ramírez AM, Ghio A, Cismondi IA, Depetris-Boldini C, Paschini-Capra A, Giner-Ayala A (2004) Evaluation of the screening of PPT1 and TPP-I in saliva in the infantile (INCL) and late infantile (LINCL) neuronal ceroid lipofuscinoses. In Proceedings of ‘Neuronal ceroid lipofuscinoses and other genetic lysosomal storage disorders: from the clinical to the molecular aspects’, Córdoba, Argentina, 18–20 September 2003. Rev Neurol 38:292–298 Halac IN, Kramer RD, Kohan R, Tapia V, Guelbert N, Oller-Ramírez AM, Ghio A, Cismondi IA, Depetris-Boldini C, Paschini-Capra A, Giner-Ayala A (2004) Evaluation of the screening of PPT1 and TPP-I in saliva in the infantile (INCL) and late infantile (LINCL) neuronal ceroid lipofuscinoses. In Proceedings of ‘Neuronal ceroid lipofuscinoses and other genetic lysosomal storage disorders: from the clinical to the molecular aspects’, Córdoba, Argentina, 18–20 September 2003. Rev Neurol 38:292–298
29.
go back to reference Das AK, Becerra CHR, Yi W, Lu J-Y, Siakotos AN, Wisniewski KE, Hofmann SL (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 102:361–370PubMed Das AK, Becerra CHR, Yi W, Lu J-Y, Siakotos AN, Wisniewski KE, Hofmann SL (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 102:361–370PubMed
30.
go back to reference Das AK, Lu JY, Hofmann SL (2001) Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum Mol Genet 10:1431–1439CrossRefPubMed Das AK, Lu JY, Hofmann SL (2001) Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum Mol Genet 10:1431–1439CrossRefPubMed
32.
go back to reference Lehtovirta M, Kyttälä A, Eskelinen E-L, Hess M, Heinonen O, Jalanko A (2001) Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum Mol Genet 10:69–75CrossRefPubMed Lehtovirta M, Kyttälä A, Eskelinen E-L, Hess M, Heinonen O, Jalanko A (2001) Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum Mol Genet 10:69–75CrossRefPubMed
33.
go back to reference Salonen T, Heinonen-Kopra O, Vesa J, Jalanko A (2001) Neuronal trafficking of palmitoyl protein thioesterase provides an excellent model to study the effects of different mutations which cause infantile neuronal ceroid lipofuscinocis. Mol Cell Neurosci 18:131–140CrossRefPubMed Salonen T, Heinonen-Kopra O, Vesa J, Jalanko A (2001) Neuronal trafficking of palmitoyl protein thioesterase provides an excellent model to study the effects of different mutations which cause infantile neuronal ceroid lipofuscinocis. Mol Cell Neurosci 18:131–140CrossRefPubMed
34.
go back to reference Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376:584–587CrossRefPubMed Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376:584–587CrossRefPubMed
35.
go back to reference Hentze MW, Kulozik AE (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96:307–310CrossRefPubMed Hentze MW, Kulozik AE (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96:307–310CrossRefPubMed
36.
go back to reference Mitchison HM, Hofmann SL, Becerra CHR, Munroe PB, Lake BD, Crow YJ, Stephenson JBP, Williams RE, Hofman IL, Taschner PEM, Martin J-J, Philippart M, Andermann E, Andermann F, Mole SE, Gardiner RM, O’Rawe AM (1998) Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum Mol Genet 7:291–297CrossRefPubMed Mitchison HM, Hofmann SL, Becerra CHR, Munroe PB, Lake BD, Crow YJ, Stephenson JBP, Williams RE, Hofman IL, Taschner PEM, Martin J-J, Philippart M, Andermann E, Andermann F, Mole SE, Gardiner RM, O’Rawe AM (1998) Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum Mol Genet 7:291–297CrossRefPubMed
37.
go back to reference Vanhanen SL, Puranen J, Autti T, Raininko R, Liewendahl K, Nikkinen P, Santavuori P, Suominen P, Vuori K, Hakkinen AM (2004) Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics 35:27–35CrossRefPubMed Vanhanen SL, Puranen J, Autti T, Raininko R, Liewendahl K, Nikkinen P, Santavuori P, Suominen P, Vuori K, Hakkinen AM (2004) Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics 35:27–35CrossRefPubMed
38.
go back to reference Santavuori P, Gottlob I, Haltia M, Rapola J, Lake BD, Tyynela J, Peltonen L (1999) CLN1—infantile and other types of NCL with GROD. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 16–36 Santavuori P, Gottlob I, Haltia M, Rapola J, Lake BD, Tyynela J, Peltonen L (1999) CLN1—infantile and other types of NCL with GROD. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 16–36
39.
go back to reference Crow YJ, Tolmie JL, Howatson AG, Patrick WJA, Stephenson JBP (1997) Batten disease in the West of Scotland 1974–1995 including five cases of the juvenile form with granular osmiophilic deposits. Neuropediatrics 28:140–144PubMed Crow YJ, Tolmie JL, Howatson AG, Patrick WJA, Stephenson JBP (1997) Batten disease in the West of Scotland 1974–1995 including five cases of the juvenile form with granular osmiophilic deposits. Neuropediatrics 28:140–144PubMed
40.
go back to reference Santorelli FM, Bertini E, Petruzzella V, Di Capua M, Calvieri S, Gasparini P, Zeviani M (1998) A novel insertion mutation (A169i) in the CLN1 gene is associated with infantile neuronal ceroid lipofuscinosis in an Italian patient. Biochem Biophys Res Commun 245:519–522CrossRefPubMed Santorelli FM, Bertini E, Petruzzella V, Di Capua M, Calvieri S, Gasparini P, Zeviani M (1998) A novel insertion mutation (A169i) in the CLN1 gene is associated with infantile neuronal ceroid lipofuscinosis in an Italian patient. Biochem Biophys Res Commun 245:519–522CrossRefPubMed
41.
go back to reference Stephenson JB, Greene ND, Leung KY, Munroe PB, Mole SE, Gardiner RM, Taschner PE, O’Regan M, Naismith K, Crow YJ, Mitchison HM (1999) The molecular basis of GROD-storing neuronal ceroid lipofuscinoses in Scotland. Mol Genet Metab 66:245–247CrossRefPubMed Stephenson JB, Greene ND, Leung KY, Munroe PB, Mole SE, Gardiner RM, Taschner PE, O’Regan M, Naismith K, Crow YJ, Mitchison HM (1999) The molecular basis of GROD-storing neuronal ceroid lipofuscinoses in Scotland. Mol Genet Metab 66:245–247CrossRefPubMed
42.
go back to reference Wisniewski KE, Connell F, Kaczmarski W, Kaczmarski A, Siakotos A, Becerra CR, Hofmann SL (1998) Palmitoyl-protein thioesterase deficiency in a novel granular variant of LINCL. Pediatr Neurol 18:119–123CrossRefPubMed Wisniewski KE, Connell F, Kaczmarski W, Kaczmarski A, Siakotos A, Becerra CR, Hofmann SL (1998) Palmitoyl-protein thioesterase deficiency in a novel granular variant of LINCL. Pediatr Neurol 18:119–123CrossRefPubMed
43.
go back to reference Mazzei R, Conforti FL, Magariello A, Bravaccio C, Militerni R, Gabriele AL, Sampaolo S, Patitucci A, Di Iorio G, Muglia M, Quattrone A (2002) A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis. J Neurol 249:1398–1400CrossRefPubMed Mazzei R, Conforti FL, Magariello A, Bravaccio C, Militerni R, Gabriele AL, Sampaolo S, Patitucci A, Di Iorio G, Muglia M, Quattrone A (2002) A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis. J Neurol 249:1398–1400CrossRefPubMed
44.
go back to reference van Diggelen OP, Thobois S, Tilikete C, Zabot MT, Keulemans JL, van Bunderen PA, Taschner PE, Losekoot M, Voznyi YV (2001) Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol 50:269–272CrossRefPubMed van Diggelen OP, Thobois S, Tilikete C, Zabot MT, Keulemans JL, van Bunderen PA, Taschner PE, Losekoot M, Voznyi YV (2001) Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol 50:269–272CrossRefPubMed
45.
go back to reference Humphreys S, Lake BD, Scholtz CL (1985) Congenital amaurotic idiocy—a pathological, histochemical, biochemical and ultrastructural study. Neuropathol Appl Neurobiol 11:475–484PubMed Humphreys S, Lake BD, Scholtz CL (1985) Congenital amaurotic idiocy—a pathological, histochemical, biochemical and ultrastructural study. Neuropathol Appl Neurobiol 11:475–484PubMed
46.
go back to reference Garborg I, Torvik A, Hals J, Tangsrud SE, Lindemann R (1987) Congenital neuronal ceroid lipofuscinosis. A case report. Acta Pathol Microbiol Immunol Scand A 95:119–125PubMed Garborg I, Torvik A, Hals J, Tangsrud SE, Lindemann R (1987) Congenital neuronal ceroid lipofuscinosis. A case report. Acta Pathol Microbiol Immunol Scand A 95:119–125PubMed
47.
go back to reference Rapola J, Salonen R, Ammala P, Santavuori P (1990) Prenatal diagnosis of the infantile type of neuronal ceroid lipofuscinosis by electron microscopic investigation of human chorionic villi. Prenat Diagn 10:553–559PubMed Rapola J, Salonen R, Ammala P, Santavuori P (1990) Prenatal diagnosis of the infantile type of neuronal ceroid lipofuscinosis by electron microscopic investigation of human chorionic villi. Prenat Diagn 10:553–559PubMed
48.
go back to reference Kohlschütter A, Lake BD (1999) NCL variants without genetic assignment. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 125–127 Kohlschütter A, Lake BD (1999) NCL variants without genetic assignment. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 125–127
49.
go back to reference Burck U, Goebel HH, Kuhlendahl HD, Meier C, Goebel KM (1981) Neuromyopathy and vitamin E deficiency in man. Neuropediatrics 12:267–278PubMed Burck U, Goebel HH, Kuhlendahl HD, Meier C, Goebel KM (1981) Neuromyopathy and vitamin E deficiency in man. Neuropediatrics 12:267–278PubMed
50.
go back to reference Wlodawer A, Li M, Dauter Z, Gustchina A, Uchida K, Oyama H, Dunn BM, Oda K (2001) Carboxyl proteinase from Pseudomonas defines a novel family of subtilisin-like enzymes. Nat Struct Biol 8:442–446CrossRefPubMed Wlodawer A, Li M, Dauter Z, Gustchina A, Uchida K, Oyama H, Dunn BM, Oda K (2001) Carboxyl proteinase from Pseudomonas defines a novel family of subtilisin-like enzymes. Nat Struct Biol 8:442–446CrossRefPubMed
51.
go back to reference Ezaki J, Takeda-Ezaki M, Kominami E (2000) Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase. J Biochem (Tokyo) 128:509–516 Ezaki J, Takeda-Ezaki M, Kominami E (2000) Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase. J Biochem (Tokyo) 128:509–516
52.
go back to reference Junaid MA, Wu G, Pullarkat RK (2000) Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis. J Neurochem 74:287–294CrossRefPubMed Junaid MA, Wu G, Pullarkat RK (2000) Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis. J Neurochem 74:287–294CrossRefPubMed
53.
go back to reference Warburton MJ, Bernardini F (2001) The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues. FEBS Lett 500:145–148CrossRefPubMed Warburton MJ, Bernardini F (2001) The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues. FEBS Lett 500:145–148CrossRefPubMed
54.
go back to reference Bernardini F, Warburton MJ (2002) The lysosomal degradation of cholecystokinin-(29–33)-amide in mouse brain is dependent on tripeptidyl peptidase: I. Implications for the degradation and storage of peptides in classical late infantile neuronal ceroid lipofuscinosis. Biochem J 366:521–529CrossRefPubMed Bernardini F, Warburton MJ (2002) The lysosomal degradation of cholecystokinin-(29–33)-amide in mouse brain is dependent on tripeptidyl peptidase: I. Implications for the degradation and storage of peptides in classical late infantile neuronal ceroid lipofuscinosis. Biochem J 366:521–529CrossRefPubMed
55.
go back to reference Kopan S, Sivasubramaniam U, Warburton MJ (2004) The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase: I. Evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis. Biochem Biophys Res Commun 319:58–65CrossRefPubMed Kopan S, Sivasubramaniam U, Warburton MJ (2004) The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase: I. Evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis. Biochem Biophys Res Commun 319:58–65CrossRefPubMed
56.
go back to reference Golabek AA, Kida E, Walus M, Wujek P, Mehta P, Wisniewski KE (2003) Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I. J Biol Chem 278:7135–7145CrossRefPubMed Golabek AA, Kida E, Walus M, Wujek P, Mehta P, Wisniewski KE (2003) Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I. J Biol Chem 278:7135–7145CrossRefPubMed
57.
go back to reference Lin L, Sohar I, Lackland H, Lobel P (2001) The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J Biol Chem 276:2249–2255PubMed Lin L, Sohar I, Lackland H, Lobel P (2001) The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J Biol Chem 276:2249–2255PubMed
58.
go back to reference Vesa J, Chin MH, Oelgeschlager K, Isosomppi J, DellAngelica EC, Jalanko A, Peltonen L (2002) Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol Biol Cell 13:2410–2420CrossRefPubMed Vesa J, Chin MH, Oelgeschlager K, Isosomppi J, DellAngelica EC, Jalanko A, Peltonen L (2002) Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol Biol Cell 13:2410–2420CrossRefPubMed
59.
go back to reference Wlodawer A, Durell SR, Li M, Oyama H, Oda K, Dunn BM (2003) A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases. BMC Struct Biol 3:8CrossRefPubMed Wlodawer A, Durell SR, Li M, Oyama H, Oda K, Dunn BM (2003) A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases. BMC Struct Biol 3:8CrossRefPubMed
60.
go back to reference Sleat DE, Donnelly RJ, Lackland H, Liu C-G, Sohar I, Pullarkat RK, Lobel P (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277:1802–1805PubMed Sleat DE, Donnelly RJ, Lackland H, Liu C-G, Sohar I, Pullarkat RK, Lobel P (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277:1802–1805PubMed
61.
go back to reference Kurachi Y, Oka A, Itoh M, Mizuguchi M, Hayashi M, Takashima S (2001) Distribution and development of CLN2 protein, the late-infantile neuronal ceroid lipofuscinosis gene product. Acta Neuropathol (Berl) 102:20–26 Kurachi Y, Oka A, Itoh M, Mizuguchi M, Hayashi M, Takashima S (2001) Distribution and development of CLN2 protein, the late-infantile neuronal ceroid lipofuscinosis gene product. Acta Neuropathol (Berl) 102:20–26
62.
go back to reference Young EP, Worthington VC, Jackson M, Winchester BG (2001) Pre- and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities. Eur J Paediatr Neurol 5(Suppl A):193–196PubMed Young EP, Worthington VC, Jackson M, Winchester BG (2001) Pre- and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities. Eur J Paediatr Neurol 5(Suppl A):193–196PubMed
63.
go back to reference Lukacs Z, Santavuori P, Keil A, Steinfeld R, Kohlschutter A (2003) Rapid and simple assay for the determination of tripeptidyl peptidase and palmitoyl protein thioesterase activities in dried blood spots. Clin Chem 49:509–511CrossRefPubMed Lukacs Z, Santavuori P, Keil A, Steinfeld R, Kohlschutter A (2003) Rapid and simple assay for the determination of tripeptidyl peptidase and palmitoyl protein thioesterase activities in dried blood spots. Clin Chem 49:509–511CrossRefPubMed
64.
go back to reference Tessa A, Simonati A, Tavoni A, Bertini E, Santorelli FM (2000) A novel nonsense mutation (Q509X) in three Italian late-infantile neuronal ceroid-lipofuscinosis children. Hum Mutat (online) 15:577CrossRef Tessa A, Simonati A, Tavoni A, Bertini E, Santorelli FM (2000) A novel nonsense mutation (Q509X) in three Italian late-infantile neuronal ceroid-lipofuscinosis children. Hum Mutat (online) 15:577CrossRef
65.
go back to reference Ju W, Zhong R, Moore S, Moroziewicz D, Currie JR, Parfrey P, Brown WT, Zhong N (2002) Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles. J Med Genet 39:822–825CrossRefPubMed Ju W, Zhong R, Moore S, Moroziewicz D, Currie JR, Parfrey P, Brown WT, Zhong N (2002) Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles. J Med Genet 39:822–825CrossRefPubMed
66.
go back to reference Claussen M, Heim P, Knispel J, Goebel HH, Kohlschutter A (1992) Incidence of neuronal ceroid lipofuscinosis in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet 42:536–538CrossRefPubMed Claussen M, Heim P, Knispel J, Goebel HH, Kohlschutter A (1992) Incidence of neuronal ceroid lipofuscinosis in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet 42:536–538CrossRefPubMed
67.
go back to reference Zhong N, Wisniewski KE, Hartikainen J, Ju W, Moroziewicz DN, McLendon L, Brooks SS, Brown WT (1998) Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis. Clin Genet 54:234–238PubMedCrossRef Zhong N, Wisniewski KE, Hartikainen J, Ju W, Moroziewicz DN, McLendon L, Brooks SS, Brown WT (1998) Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis. Clin Genet 54:234–238PubMedCrossRef
68.
go back to reference Ko CH, Kong CK, Chow TC, Lee KC (2001) Classic late infantile neuronal ceroid lipofuscinosis in a Chinese patient. Hong Kong Med J 7:93–96PubMed Ko CH, Kong CK, Chow TC, Lee KC (2001) Classic late infantile neuronal ceroid lipofuscinosis in a Chinese patient. Hong Kong Med J 7:93–96PubMed
69.
go back to reference Lam CW, Poon PM, Tong SF, Ko CH (2001) Two novel CLN2 gene mutations in a Chinese patient with classical late-infantile neuronal ceroid lipofuscinosis. Am J Med Genet 99:161–163CrossRefPubMed Lam CW, Poon PM, Tong SF, Ko CH (2001) Two novel CLN2 gene mutations in a Chinese patient with classical late-infantile neuronal ceroid lipofuscinosis. Am J Med Genet 99:161–163CrossRefPubMed
70.
go back to reference Lavrov AY, Ilyna ES, Zakharova EY, Boukina AM, Tishkanina SV (2002) The first three Russian cases of classical, late-infantile, neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol 6:161–164CrossRefPubMed Lavrov AY, Ilyna ES, Zakharova EY, Boukina AM, Tishkanina SV (2002) The first three Russian cases of classical, late-infantile, neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol 6:161–164CrossRefPubMed
71.
go back to reference Barisic N, Logan P, Pikija S, Skarpa D, Blau N (2003) R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis. Croat Med J 44:489–493PubMed Barisic N, Logan P, Pikija S, Skarpa D, Blau N (2003) R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis. Croat Med J 44:489–493PubMed
72.
go back to reference Sleat DE, Gin RM, Sohar I, Wisniewski K, Sklower-Brooks S, Pullarkat RK, Palmer DN, Lerner TJ, Boustany R-M, Uldall P, Siakotos AN, Donnelly RJ, Lobel P (1999) Mutational analysis of the defective protease in classical late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet 64:1511–1523CrossRefPubMed Sleat DE, Gin RM, Sohar I, Wisniewski K, Sklower-Brooks S, Pullarkat RK, Palmer DN, Lerner TJ, Boustany R-M, Uldall P, Siakotos AN, Donnelly RJ, Lobel P (1999) Mutational analysis of the defective protease in classical late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet 64:1511–1523CrossRefPubMed
73.
go back to reference Zhong N, Moroziewicz D, Jurkiewicz A, Ju W, Johnston L, Wisniewski KE, Brown WT (2000) Heterogeneity of late infantile neuronal ceroid lipofuscinoses. Genet Med 2:312–318PubMedCrossRef Zhong N, Moroziewicz D, Jurkiewicz A, Ju W, Johnston L, Wisniewski KE, Brown WT (2000) Heterogeneity of late infantile neuronal ceroid lipofuscinoses. Genet Med 2:312–318PubMedCrossRef
74.
go back to reference Lin L, Lobel P (2001) Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations. Hum Mutat 18:165 Lin L, Lobel P (2001) Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations. Hum Mutat 18:165
75.
go back to reference Steinfeld R, Heim P, Von Gregory H, Meyer K, Ullrich K, Goebel HH, Kohlschutter A (2002) Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 112:347–354CrossRefPubMed Steinfeld R, Heim P, Von Gregory H, Meyer K, Ullrich K, Goebel HH, Kohlschutter A (2002) Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 112:347–354CrossRefPubMed
76.
go back to reference Wisniewski KE, Kida E, Connell F, Zhong N (2000) Neuronal ceroid lipofuscinoses: research update. Neurol Sci 21:S49–S56CrossRefPubMed Wisniewski KE, Kida E, Connell F, Zhong N (2000) Neuronal ceroid lipofuscinoses: research update. Neurol Sci 21:S49–S56CrossRefPubMed
77.
go back to reference Chow CW, Borg J, Billson VR, Lake BD (1993) Fetal tissue involvement in the late infantile type of neuronal ceroid lipofuscinosis. Prenat Diagn 13:833–841PubMed Chow CW, Borg J, Billson VR, Lake BD (1993) Fetal tissue involvement in the late infantile type of neuronal ceroid lipofuscinosis. Prenat Diagn 13:833–841PubMed
78.
go back to reference Williams RE, Gottlob I, Lake BD, Goebel HH, Winchester BG, Wheeler RB (1999) CLN2—classic late infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 37–54 Williams RE, Gottlob I, Lake BD, Goebel HH, Winchester BG, Wheeler RB (1999) CLN2—classic late infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 37–54
79.
go back to reference Wisniewski KE, Kaczmarski A, Kida E, Connell F, Kaczmarski W, Michalewski MP, Moroziewicz DN, Zhong N, Das AM, Jolly RD, Kohlschutter A (1999) Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 66:248–252CrossRefPubMed Wisniewski KE, Kaczmarski A, Kida E, Connell F, Kaczmarski W, Michalewski MP, Moroziewicz DN, Zhong N, Das AM, Jolly RD, Kohlschutter A (1999) Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 66:248–252CrossRefPubMed
80.
go back to reference Goebel HH, Kominami E, Neuen-Jacob E, Wheeler RB (2001) Morphological studies on CLN2. Eur J Paediatr Neurol 5(Suppl A):203–207CrossRefPubMed Goebel HH, Kominami E, Neuen-Jacob E, Wheeler RB (2001) Morphological studies on CLN2. Eur J Paediatr Neurol 5(Suppl A):203–207CrossRefPubMed
81.
go back to reference Rowan SA, Lake BD (1995) Tissue and cellular distribution of subunit c of ATP synthase in Batten disease (neuronal ceroid-lipofuscinosis). Am J Med Genet 57:172–176CrossRefPubMed Rowan SA, Lake BD (1995) Tissue and cellular distribution of subunit c of ATP synthase in Batten disease (neuronal ceroid-lipofuscinosis). Am J Med Genet 57:172–176CrossRefPubMed
82.
go back to reference Caillaud C, Manicom J, Puech JP, Lobel P, Poenaru L (1999) Enzymatic and molecular pre natal and postnatal diagnosis of ceroid lipofuscinoses. Am J Hum Genet 65(Suppl):A232 Caillaud C, Manicom J, Puech JP, Lobel P, Poenaru L (1999) Enzymatic and molecular pre natal and postnatal diagnosis of ceroid lipofuscinoses. Am J Hum Genet 65(Suppl):A232
83.
go back to reference Hartikainen JM, Ju W, Wisniewski KE, Moroziewicz DN, Kaczmarski AL, McLendon L, Zhong D, Suarez CT, Brown WT, Zhong N (1999) Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Mol Genet Metab 67:162–168CrossRefPubMed Hartikainen JM, Ju W, Wisniewski KE, Moroziewicz DN, Kaczmarski AL, McLendon L, Zhong D, Suarez CT, Brown WT, Zhong N (1999) Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Mol Genet Metab 67:162–168CrossRefPubMed
84.
go back to reference Tsiakas K, Steinfeld R, Storch S, Ezaki J, Lukacs Z, Kominami E, Kohlschutter A, Ullrich K, Braulke T (2004) Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity. Glycobiology 14:1C–5CCrossRefPubMed Tsiakas K, Steinfeld R, Storch S, Ezaki J, Lukacs Z, Kominami E, Kohlschutter A, Ullrich K, Braulke T (2004) Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity. Glycobiology 14:1C–5CCrossRefPubMed
85.
go back to reference Wujek P, Kida E, Walus M, Wisniewski KE, Golabek AA (2004) N-Glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I. J Biol Chem 279:12827–12839CrossRefPubMed Wujek P, Kida E, Walus M, Wisniewski KE, Golabek AA (2004) N-Glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I. J Biol Chem 279:12827–12839CrossRefPubMed
86.
go back to reference Simonati A, Santorum E, Tessa A, Polo A, Simonetti F, Bernardina BD, Santorelli FM, Rizzuto N (2000) A CLN2 gene nonsense mutation is associated with severe caudate atrophy and dystonia in LINCL. Neuropediatrics 31:199–201CrossRefPubMed Simonati A, Santorum E, Tessa A, Polo A, Simonetti F, Bernardina BD, Santorelli FM, Rizzuto N (2000) A CLN2 gene nonsense mutation is associated with severe caudate atrophy and dystonia in LINCL. Neuropediatrics 31:199–201CrossRefPubMed
87.
go back to reference Ezaki J, Takeda-Ezaki M, Koike M, Ohsawa Y, Taka H, Mineki R, Murayama K, Uchiyama Y, Ueno T, Kominami E (2003) Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein. J Neurochem 87:1296–1308CrossRefPubMed Ezaki J, Takeda-Ezaki M, Koike M, Ohsawa Y, Taka H, Mineki R, Murayama K, Uchiyama Y, Ueno T, Kominami E (2003) Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein. J Neurochem 87:1296–1308CrossRefPubMed
88.
go back to reference Haskell RE, Carr CJ, Pearce DA, Bennett MJ, Davidson BL (2000) Batten disease: evaluation of CLN3 mutations on protein localization and function. Hum Mol Genet 9:735–744CrossRefPubMed Haskell RE, Carr CJ, Pearce DA, Bennett MJ, Davidson BL (2000) Batten disease: evaluation of CLN3 mutations on protein localization and function. Hum Mol Genet 9:735–744CrossRefPubMed
89.
go back to reference Järvelä I, Sainio M, Rantamaki T, Olkkonen VM, Carpén O, Peltonen L, Jalanko A (1998) Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet 7:85–90CrossRefPubMed Järvelä I, Sainio M, Rantamaki T, Olkkonen VM, Carpén O, Peltonen L, Jalanko A (1998) Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet 7:85–90CrossRefPubMed
90.
go back to reference Järvelä I, Lehtovirta M, Tikkanen R, Kyttälä A, Jalanko A (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum Mol Genet 8:1091–1098CrossRefPubMed Järvelä I, Lehtovirta M, Tikkanen R, Kyttälä A, Jalanko A (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum Mol Genet 8:1091–1098CrossRefPubMed
91.
go back to reference Luiro K, Kopra O, Lehtovirta M, Jalanko A (2001) CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum Mol Genet 10:2123–2131CrossRefPubMed Luiro K, Kopra O, Lehtovirta M, Jalanko A (2001) CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum Mol Genet 10:2123–2131CrossRefPubMed
92.
go back to reference Janes RW, Munroe PB, Mitchsion HM, Gardiner RM, Mole SE, Wallace BA (1996) A model for Batten disease protein CLN3: functional implications from homology and mutations. FEBS Lett 399:75–77CrossRefPubMed Janes RW, Munroe PB, Mitchsion HM, Gardiner RM, Mole SE, Wallace BA (1996) A model for Batten disease protein CLN3: functional implications from homology and mutations. FEBS Lett 399:75–77CrossRefPubMed
93.
go back to reference Mao Q, Foster BJ, Xia H, Davidson BL (2003) Membrane topology of CLN3, the protein underlying Batten disease. FEBS Lett 541:40–46CrossRefPubMed Mao Q, Foster BJ, Xia H, Davidson BL (2003) Membrane topology of CLN3, the protein underlying Batten disease. FEBS Lett 541:40–46CrossRefPubMed
94.
go back to reference Kyttälä A, Ihrke G, Vesa J, Schell MJ, Luzio JP (2003) Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells. Mol Biol Cell Kyttälä A, Ihrke G, Vesa J, Schell MJ, Luzio JP (2003) Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells. Mol Biol Cell
95.
go back to reference Rakheja D, Narayan SB, Pastor JV, Bennett MJ (2004) CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes). Biochem Biophys Res Commun 317:988–991CrossRefPubMed Rakheja D, Narayan SB, Pastor JV, Bennett MJ (2004) CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes). Biochem Biophys Res Commun 317:988–991CrossRefPubMed
96.
go back to reference Pearce DA, Ferea T, Nosel SA, Das B, Sherman F (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat Genet 22:55–58CrossRefPubMed Pearce DA, Ferea T, Nosel SA, Das B, Sherman F (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat Genet 22:55–58CrossRefPubMed
97.
go back to reference Chattopadhyay S, Muzaffar NE, Sherman F, Pearce DA (2000) The yeast model for Batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis. J Bacteriol 182:6418–6423CrossRefPubMed Chattopadhyay S, Muzaffar NE, Sherman F, Pearce DA (2000) The yeast model for Batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis. J Bacteriol 182:6418–6423CrossRefPubMed
98.
go back to reference The International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82:949–957 The International Batten Disease Consortium (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82:949–957
99.
go back to reference Mitchison HM, O’Rawe AM, Taschner PEM, Santavuori P, de Vos N, Breuning MH, Mole SE, Gardiner RM, Järvelä IE (1995) Batten disease (CLN3): linkage disequilibrium mapping in the Finnish population and analysis of European haplotypes. Am J Hum Genet 56:654–662PubMed Mitchison HM, O’Rawe AM, Taschner PEM, Santavuori P, de Vos N, Breuning MH, Mole SE, Gardiner RM, Järvelä IE (1995) Batten disease (CLN3): linkage disequilibrium mapping in the Finnish population and analysis of European haplotypes. Am J Hum Genet 56:654–662PubMed
100.
go back to reference Munroe PB, Mitchison HM, O’Rawe AM, Anderson JW, Boustany R-M, Lerner TJ, Taschner PEM, de Vos N, Breuning MH, Gardiner RM, Mole SE (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 61:310–316PubMed Munroe PB, Mitchison HM, O’Rawe AM, Anderson JW, Boustany R-M, Lerner TJ, Taschner PEM, de Vos N, Breuning MH, Gardiner RM, Mole SE (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 61:310–316PubMed
101.
go back to reference Munroe PB, O’Rawe AM, Mitchison HM, Järvelä IE, Santavuouri P, Lerner TJ, Taschner PEM, Gardiner RM, Mole SE (1997) Strategy for mutation detection in CLN3: characterisation of two Finnish mutations. Neuropediatrics 28:15–17PubMed Munroe PB, O’Rawe AM, Mitchison HM, Järvelä IE, Santavuouri P, Lerner TJ, Taschner PEM, Gardiner RM, Mole SE (1997) Strategy for mutation detection in CLN3: characterisation of two Finnish mutations. Neuropediatrics 28:15–17PubMed
102.
go back to reference Järvelä I, Autti T, Lamminranta S, Åberg L, Raininko R, Santavuori P (1997) Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol 42:799–802CrossRefPubMed Järvelä I, Autti T, Lamminranta S, Åberg L, Raininko R, Santavuori P (1997) Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol 42:799–802CrossRefPubMed
103.
go back to reference Lauronen L, Munroe PB, Järvelä I, Autti T, Mitchison HM, O’Rawe AM, Gardiner RM, Mole SE, Puranen J, Häkkinen A-M, Kirveskari E, Santavuori P (1999) Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 52:360–365PubMed Lauronen L, Munroe PB, Järvelä I, Autti T, Mitchison HM, O’Rawe AM, Gardiner RM, Mole SE, Puranen J, Häkkinen A-M, Kirveskari E, Santavuori P (1999) Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 52:360–365PubMed
104.
go back to reference Goebel HH, Pilz H, Gullotta F (1976) The protracted form of juvenile neuronal ceroid-lipofuscinosis. Acta Neuropathol (Berl) 36:393–396CrossRef Goebel HH, Pilz H, Gullotta F (1976) The protracted form of juvenile neuronal ceroid-lipofuscinosis. Acta Neuropathol (Berl) 36:393–396CrossRef
105.
go back to reference Elleder M, Lake BD, Goebel HH, Rapola J, Haltia M, Carpenter S (1999) Definitions of the ultrastructural patterns found in NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 5–15 Elleder M, Lake BD, Goebel HH, Rapola J, Haltia M, Carpenter S (1999) Definitions of the ultrastructural patterns found in NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 5–15
106.
go back to reference Hofman I, Kohlschütter A, Santavuori P, Gottlob I, Goebel HH, Lake BD, Schutgens RBH, Greene NDE, Leung K-Y, Mitchison HM, Munroe PB, Taschner PEM (1999) CLN3—juvenile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 55–70 Hofman I, Kohlschütter A, Santavuori P, Gottlob I, Goebel HH, Lake BD, Schutgens RBH, Greene NDE, Leung K-Y, Mitchison HM, Munroe PB, Taschner PEM (1999) CLN3—juvenile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 55–70
107.
go back to reference Goebel HH (2004) Introduction. Symposium: the neuronal ceroid lipofuscinopses (NCL)—a group of lysosomal storage diseases come of age. Brain Pathol 14:59–60CrossRef Goebel HH (2004) Introduction. Symposium: the neuronal ceroid lipofuscinopses (NCL)—a group of lysosomal storage diseases come of age. Brain Pathol 14:59–60CrossRef
108.
go back to reference Goebel HH, Zeman W, Pilz H (1975) Significance of muscle biopsies in neuronal ceroid-lipofuscinoses. J Neurol Neurosurg Psychiatry 38:985–993PubMed Goebel HH, Zeman W, Pilz H (1975) Significance of muscle biopsies in neuronal ceroid-lipofuscinoses. J Neurol Neurosurg Psychiatry 38:985–993PubMed
109.
go back to reference Munroe PB, Rapola J, Mitchison HM, Mole SE, Gardiner RM, Järvelä IE (1996) Prenatal diagnosis of Batten disease. Lancet 347:1014–1015CrossRefPubMed Munroe PB, Rapola J, Mitchison HM, Mole SE, Gardiner RM, Järvelä IE (1996) Prenatal diagnosis of Batten disease. Lancet 347:1014–1015CrossRefPubMed
110.
go back to reference Lake BD, Young EP, Winchester BG (1998) Prenatal diagnosis of lysosomal storage diseases. Brain Pathol 8:133–149PubMedCrossRef Lake BD, Young EP, Winchester BG (1998) Prenatal diagnosis of lysosomal storage diseases. Brain Pathol 8:133–149PubMedCrossRef
111.
go back to reference Goebel HH, Zeman W, Patel VK, Pullarkat RK, Lenard HG (1979) On the ultrastructural diversity and essence of residual bodies in neuronal ceroid-lipofuscinosis. Mech Ageing Dev 10:53–70CrossRefPubMed Goebel HH, Zeman W, Patel VK, Pullarkat RK, Lenard HG (1979) On the ultrastructural diversity and essence of residual bodies in neuronal ceroid-lipofuscinosis. Mech Ageing Dev 10:53–70CrossRefPubMed
112.
go back to reference Goebel HH, Kohlschutter A, Lenard HG (1982) Morphologic and chemical biopsy findings in mucolipidosis IV. Clin Neuropathol 1:73–82PubMed Goebel HH, Kohlschutter A, Lenard HG (1982) Morphologic and chemical biopsy findings in mucolipidosis IV. Clin Neuropathol 1:73–82PubMed
113.
go back to reference Bargal R, Goebel HH, Latta E, Bach G (2002) Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. Neuropediatrics 33:199–202CrossRefPubMed Bargal R, Goebel HH, Latta E, Bach G (2002) Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. Neuropediatrics 33:199–202CrossRefPubMed
114.
go back to reference Goebel HH (1993) Protracted juvenile neuronal ceroid-lipofuscinosis. J Inherit Metab Dis 16:233–236CrossRefPubMed Goebel HH (1993) Protracted juvenile neuronal ceroid-lipofuscinosis. J Inherit Metab Dis 16:233–236CrossRefPubMed
115.
go back to reference Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Sklower-Brooks S, Brown WT (1998) Studies of atypical JNCL suggest overlapping with other NCL forms. Pediatr Neurol 18:36–40CrossRefPubMed Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Sklower-Brooks S, Brown WT (1998) Studies of atypical JNCL suggest overlapping with other NCL forms. Pediatr Neurol 18:36–40CrossRefPubMed
116.
go back to reference Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Kida E, Brown WT, Schwarz KO, Lazzarini AM, Rubin AJ, Stenroos ES, Johnson WG, Wisniewski TM (1998) Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Ann Neurol 43:106–110CrossRefPubMed Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Kida E, Brown WT, Schwarz KO, Lazzarini AM, Rubin AJ, Stenroos ES, Johnson WG, Wisniewski TM (1998) Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Ann Neurol 43:106–110CrossRefPubMed
117.
go back to reference Åberg L, Järvelä I, Rapola J, Autti T, Kirveskari E, Lappi M, Sipilä L, Santavuori P (1998) Atypical juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposit-like inclusions in the autonomic nerve cells of the gut wall. Acta Neuropathol 95:306–312CrossRefPubMed Åberg L, Järvelä I, Rapola J, Autti T, Kirveskari E, Lappi M, Sipilä L, Santavuori P (1998) Atypical juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposit-like inclusions in the autonomic nerve cells of the gut wall. Acta Neuropathol 95:306–312CrossRefPubMed
118.
go back to reference de los Reyes E, Dyken PR, Phillips P, Brodsky M, Bates S, Glasier C, Mrak RE (2004) Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. J Child Neurol 19:42–46PubMed de los Reyes E, Dyken PR, Phillips P, Brodsky M, Bates S, Glasier C, Mrak RE (2004) Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. J Child Neurol 19:42–46PubMed
119.
go back to reference Boehme DH, Cottrell JC, Leonberg SC, Zeman W (1971) A dominant form of neuronal ceroid-lipofuscinosis. Brain 94:745–760PubMed Boehme DH, Cottrell JC, Leonberg SC, Zeman W (1971) A dominant form of neuronal ceroid-lipofuscinosis. Brain 94:745–760PubMed
120.
go back to reference Nijssen PC, Ceuterick C, van Diggelen OP, Elleder M, Martin JJ, Teepen JL, Tyynela J, Roos RA (2003) Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency. Brain Pathol 13:574–581PubMedCrossRef Nijssen PC, Ceuterick C, van Diggelen OP, Elleder M, Martin JJ, Teepen JL, Tyynela J, Roos RA (2003) Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency. Brain Pathol 13:574–581PubMedCrossRef
121.
go back to reference Ferrer I, Arbizu T, Pena J, Serra JP (1980) A Golgi and ultrastructural study of a dominant form of Kufs’ disease. J Neurol 222:183–190CrossRefPubMed Ferrer I, Arbizu T, Pena J, Serra JP (1980) A Golgi and ultrastructural study of a dominant form of Kufs’ disease. J Neurol 222:183–190CrossRefPubMed
122.
go back to reference Dyken P, Wisniewski K (1995) Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms. Am J Med Genet 57:150–154CrossRefPubMed Dyken P, Wisniewski K (1995) Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms. Am J Med Genet 57:150–154CrossRefPubMed
123.
go back to reference Josephson SA, Schmidt RE, Millsap P, McManus DQ, Morris JC (2001) Autosomal dominant Kufs’ disease: a cause of early onset dementia. J Neurol Sci 188:51–60CrossRefPubMed Josephson SA, Schmidt RE, Millsap P, McManus DQ, Morris JC (2001) Autosomal dominant Kufs’ disease: a cause of early onset dementia. J Neurol Sci 188:51–60CrossRefPubMed
124.
go back to reference Berkovic SF, Carpenter S, Andermann F, Andermann E, Wolfe LS (1988) Kufs’ disease: a critical reappraisal. Brain 111:27–62PubMed Berkovic SF, Carpenter S, Andermann F, Andermann E, Wolfe LS (1988) Kufs’ disease: a critical reappraisal. Brain 111:27–62PubMed
125.
go back to reference Sadzot B, Reznik M, Arrese-Estrada JE, Franck G (2000) Familial Kufs’ disease presenting as a progressive myoclonic epilepsy. J Neurol 247:447–454CrossRefPubMed Sadzot B, Reznik M, Arrese-Estrada JE, Franck G (2000) Familial Kufs’ disease presenting as a progressive myoclonic epilepsy. J Neurol 247:447–454CrossRefPubMed
126.
go back to reference Constantinidis J, Wisniewski KE, Wisniewski TM (1992) The adult and a new late adult forms of neuronal ceroid lipofuscinosis. Acta Neuropathol (Berl) 83:461–468CrossRef Constantinidis J, Wisniewski KE, Wisniewski TM (1992) The adult and a new late adult forms of neuronal ceroid lipofuscinosis. Acta Neuropathol (Berl) 83:461–468CrossRef
127.
go back to reference Dom R, Brucher JM, Ceuterick C, Carton H, Martin JJ (1979) Adult ceroid-lipofuscinosis (Kufs’ disease) in two brothers. Retinal and visceral storage in one; diagnostic muscle biopsy in the other. Acta Neuropathol (Berl) 45:67–72CrossRef Dom R, Brucher JM, Ceuterick C, Carton H, Martin JJ (1979) Adult ceroid-lipofuscinosis (Kufs’ disease) in two brothers. Retinal and visceral storage in one; diagnostic muscle biopsy in the other. Acta Neuropathol (Berl) 45:67–72CrossRef
128.
go back to reference Vercruyssen A, Martin JJ, Ceuterick C, Jacobs K, Swerts L (1982) Adult ceroid-lipofuscinosis: diagnostic value of biopsies and of neurophysiological investigations. J Neurol Neurosurg Psychiatry 45:1056–1059PubMedCrossRef Vercruyssen A, Martin JJ, Ceuterick C, Jacobs K, Swerts L (1982) Adult ceroid-lipofuscinosis: diagnostic value of biopsies and of neurophysiological investigations. J Neurol Neurosurg Psychiatry 45:1056–1059PubMedCrossRef
129.
go back to reference Martin JJ, Libert J, Ceuterick C (1987) Ultrastructure of brain and retina in Kufs’ disease (adult type-ceroid-lipofuscinosis). Clin Neuropathol 6:231–235PubMed Martin JJ, Libert J, Ceuterick C (1987) Ultrastructure of brain and retina in Kufs’ disease (adult type-ceroid-lipofuscinosis). Clin Neuropathol 6:231–235PubMed
130.
go back to reference Isosomppi J, Vesa J, Jalanko A, Peltonen L (2002) Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum Mol Genet 11:885–891CrossRefPubMed Isosomppi J, Vesa J, Jalanko A, Peltonen L (2002) Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum Mol Genet 11:885–891CrossRefPubMed
131.
go back to reference Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 19:286–288CrossRefPubMed Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 19:286–288CrossRefPubMed
132.
go back to reference Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P, Hofman I, Peltonen L, Järvelä I (2000) Phenotype–genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 55:579–581PubMed Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P, Hofman I, Peltonen L, Järvelä I (2000) Phenotype–genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 55:579–581PubMed
133.
go back to reference Pineda-Trujillo N, Cornejo W, Wheeler RB, Múnera S, Valencia A, Agudelo-Arango J, Cogollo A, Anderson G, Bedoya G, Mole SE, Ruíz-Linares A (2004) A novel mutation in CLN5 underlying juvenile onset neuronal ceroid lipofuscinosis in South America. Neurology (in press) Pineda-Trujillo N, Cornejo W, Wheeler RB, Múnera S, Valencia A, Agudelo-Arango J, Cogollo A, Anderson G, Bedoya G, Mole SE, Ruíz-Linares A (2004) A novel mutation in CLN5 underlying juvenile onset neuronal ceroid lipofuscinosis in South America. Neurology (in press)
134.
go back to reference Santavuori P, Rapola J, Nuutila A, Raininko R, Lappi M, Launes J, Herva R, Saino K (1991) The spectrum of Jansky–Bielschowsky disease. Neuropediatrics 22:92–96PubMed Santavuori P, Rapola J, Nuutila A, Raininko R, Lappi M, Launes J, Herva R, Saino K (1991) The spectrum of Jansky–Bielschowsky disease. Neuropediatrics 22:92–96PubMed
135.
go back to reference Autti T, Raininko R, Launes J, Nuutila A, Santavuori P (1992) Jansky–Bielschowsky variant disease: CT, MRI, and SPECT findings. Paediatric Neurol 8:121–126CrossRef Autti T, Raininko R, Launes J, Nuutila A, Santavuori P (1992) Jansky–Bielschowsky variant disease: CT, MRI, and SPECT findings. Paediatric Neurol 8:121–126CrossRef
136.
go back to reference Lauronen L, Huttunen J, Kirveskari E, Wikstrom H, Sainio K, Autti T, Santavuori P (2002) Enlarged SI and SII somatosensory evoked responses in the CLN5 form of neuronal ceroid lipofuscinosis. Clin Neurophysiol 113:1491–1500CrossRefPubMed Lauronen L, Huttunen J, Kirveskari E, Wikstrom H, Sainio K, Autti T, Santavuori P (2002) Enlarged SI and SII somatosensory evoked responses in the CLN5 form of neuronal ceroid lipofuscinosis. Clin Neurophysiol 113:1491–1500CrossRefPubMed
137.
go back to reference Santavuori P, Rapola J, Saino K, Raitta C (1982) A variant of Jansky–Bielschowsky disease. Neuropediatrics 13:135–141PubMed Santavuori P, Rapola J, Saino K, Raitta C (1982) A variant of Jansky–Bielschowsky disease. Neuropediatrics 13:135–141PubMed
138.
go back to reference Tyynelä J, Suopanki J, Santavuori P, Baumann M, Haltia M (1997) Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry. J Neuropathol Exp Neurol 56:369–375PubMed Tyynelä J, Suopanki J, Santavuori P, Baumann M, Haltia M (1997) Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry. J Neuropathol Exp Neurol 56:369–375PubMed
139.
go back to reference Rapola J, Lake BD (2000) Lymphocyte inclusions in Finnish-variant late infantile neuronal ceroid lipofuscinosis (CLN5). Neuropediatrics 31:33–34CrossRefPubMed Rapola J, Lake BD (2000) Lymphocyte inclusions in Finnish-variant late infantile neuronal ceroid lipofuscinosis (CLN5). Neuropediatrics 31:33–34CrossRefPubMed
140.
go back to reference Gao H, Boustany RM, Espinola JA, Cotman SL, Srinidhi L, Antonellis KA, Gillis T, Qin X, Liu S, Donahue LR, Bronson RT, Faust JR, Stout D, Haines JL, Lerner TJ, MacDonald ME (2002) Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet 70:324–335CrossRefPubMed Gao H, Boustany RM, Espinola JA, Cotman SL, Srinidhi L, Antonellis KA, Gillis T, Qin X, Liu S, Donahue LR, Bronson RT, Faust JR, Stout D, Haines JL, Lerner TJ, MacDonald ME (2002) Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet 70:324–335CrossRefPubMed
141.
go back to reference Wheeler RB, Sharp JD, Schultz RA, Joslin JM, Williams RE, Mole SE (2002) The gene mutated in variant late infantile neuronal ceroid lipofuscinosis (CLN6) and nclf mutant mice encodes a novel predicted transmembrane protein. Am J Hum Genet 70:537–542CrossRefPubMed Wheeler RB, Sharp JD, Schultz RA, Joslin JM, Williams RE, Mole SE (2002) The gene mutated in variant late infantile neuronal ceroid lipofuscinosis (CLN6) and nclf mutant mice encodes a novel predicted transmembrane protein. Am J Hum Genet 70:537–542CrossRefPubMed
142.
go back to reference Mole SE, Michaux G, Codlin S, Wheeler RB, Sharp JD, Cutler DF (2004) CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp Cell Res 298:399–406CrossRefPubMed Mole SE, Michaux G, Codlin S, Wheeler RB, Sharp JD, Cutler DF (2004) CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp Cell Res 298:399–406CrossRefPubMed
143.
go back to reference Heine C, Koch B, Storch S, Kohlschutter A, Palmer DN, Braulke T (2004) Defective ER-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J Biol Chem 279:22347–22352CrossRefPubMed Heine C, Koch B, Storch S, Kohlschutter A, Palmer DN, Braulke T (2004) Defective ER-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A. J Biol Chem 279:22347–22352CrossRefPubMed
144.
go back to reference Sharp JD, Wheeler RB, Parker KA, Gardiner RM, Williams RE, Mole SE (2003) Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis. Hum Mutat 22:35–42CrossRefPubMed Sharp JD, Wheeler RB, Parker KA, Gardiner RM, Williams RE, Mole SE (2003) Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis. Hum Mutat 22:35–42CrossRefPubMed
145.
go back to reference Lake BD, Cavanagh NPC (1978) Early-juvenile Batten’s disease—a recognisable subgroup distinct from other forms of Batten’s disease. J Neurol Sci 36:265–271CrossRefPubMed Lake BD, Cavanagh NPC (1978) Early-juvenile Batten’s disease—a recognisable subgroup distinct from other forms of Batten’s disease. J Neurol Sci 36:265–271CrossRefPubMed
146.
go back to reference Kimura S, Goebel HH (1987) Electron microscopic studies on skin and lymphocytes in early juvenile neuronal ceroid lipofuscinosis. Brain Dev 9:576–580PubMed Kimura S, Goebel HH (1987) Electron microscopic studies on skin and lymphocytes in early juvenile neuronal ceroid lipofuscinosis. Brain Dev 9:576–580PubMed
147.
go back to reference Andermann E, Jacob JC, Andermann F, Carpenter S, Wolfe L, Berkovic SF (1988) The Newfoundland aggregate of neuronal ceroid lipofuscinosis. Am J Med Genet Suppl 5:111–116CrossRefPubMed Andermann E, Jacob JC, Andermann F, Carpenter S, Wolfe L, Berkovic SF (1988) The Newfoundland aggregate of neuronal ceroid lipofuscinosis. Am J Med Genet Suppl 5:111–116CrossRefPubMed
148.
go back to reference Wheeler RB, Sharp JD, Mitchell WA, Bate SL, Williams RE, Lake BD, Gardiner RM (1999) A new locus for variant late infantile neuronal ceroid lipofuscinosis (LINCL)—CLN7. Mol Genet Metab 66:337–338CrossRefPubMed Wheeler RB, Sharp JD, Mitchell WA, Bate SL, Williams RE, Lake BD, Gardiner RM (1999) A new locus for variant late infantile neuronal ceroid lipofuscinosis (LINCL)—CLN7. Mol Genet Metab 66:337–338CrossRefPubMed
149.
go back to reference Peña JA, Cardozo JJ, Montiel CM, Molina OM, Boustany R (2001) Serial MRI findings in the Costa Rican variant of neuronal ceroid-lipofuscinosis. Pediatr Neurol 25:78–80CrossRefPubMed Peña JA, Cardozo JJ, Montiel CM, Molina OM, Boustany R (2001) Serial MRI findings in the Costa Rican variant of neuronal ceroid-lipofuscinosis. Pediatr Neurol 25:78–80CrossRefPubMed
150.
go back to reference Elleder M, Franc J, Kraus J, Nevsímalová S, Sixtová K, Zeman J (1997) Neuronal ceroid lipofuscinosis in the Czech Republic: analysis of 57 cases. Report of the ‘Prague NCL Group’. Eur J Paediatr Neurol 4:109–114CrossRef Elleder M, Franc J, Kraus J, Nevsímalová S, Sixtová K, Zeman J (1997) Neuronal ceroid lipofuscinosis in the Czech Republic: analysis of 57 cases. Report of the ‘Prague NCL Group’. Eur J Paediatr Neurol 4:109–114CrossRef
151.
go back to reference Teixeira C, Guimaraes A, Bessa C, Ferreira MJ, Lopes L, Pinto E, Pinto R, Boustany RM, Sa Miranda MC, Ribeiro MG (2003) Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. J Neurol 250:661–667CrossRefPubMed Teixeira C, Guimaraes A, Bessa C, Ferreira MJ, Lopes L, Pinto E, Pinto R, Boustany RM, Sa Miranda MC, Ribeiro MG (2003) Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. J Neurol 250:661–667CrossRefPubMed
152.
go back to reference Teixeira CA, Espinola JA, Huo L, Kohlschütter J, Persaud Sawin D-A, Minassian B, Bessa CJP, Guimarães A, Stephan AA, Clara Sà Miranda M, MacDonald ME, Gil Ribeiro M, Boustany R-M (2003) Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis. Hum Mutat 21:502–508CrossRefPubMed Teixeira CA, Espinola JA, Huo L, Kohlschütter J, Persaud Sawin D-A, Minassian B, Bessa CJP, Guimarães A, Stephan AA, Clara Sà Miranda M, MacDonald ME, Gil Ribeiro M, Boustany R-M (2003) Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis. Hum Mutat 21:502–508CrossRefPubMed
153.
go back to reference Nardocci N, Morbin M, Bugiani M, Lamantea E, Bugiani O (2000) Neuronal ceroid lipofuscinosis: detection of atypical forms. Neurol Sci 21:S57–S61CrossRefPubMed Nardocci N, Morbin M, Bugiani M, Lamantea E, Bugiani O (2000) Neuronal ceroid lipofuscinosis: detection of atypical forms. Neurol Sci 21:S57–S61CrossRefPubMed
154.
go back to reference Binelli S, Canafoglia L, Panzica F, Pozzi A, Franceschetti S (2000) Electroencephalographic features in a series of patients with neuronal ceroid lipofuscinoses. Neurol Sci 21:S83–S87CrossRefPubMed Binelli S, Canafoglia L, Panzica F, Pozzi A, Franceschetti S (2000) Electroencephalographic features in a series of patients with neuronal ceroid lipofuscinoses. Neurol Sci 21:S83–S87CrossRefPubMed
155.
go back to reference Scaioli V, Nardocci N (2000) A pathophysiological study of neuronal ceroid lipofuscinoses in 17 patients: critical review and methodological proposal. Neurol Sci 21:S89–S92CrossRefPubMed Scaioli V, Nardocci N (2000) A pathophysiological study of neuronal ceroid lipofuscinoses in 17 patients: critical review and methodological proposal. Neurol Sci 21:S89–S92CrossRefPubMed
156.
go back to reference Veneselli E, Biancheri R, Perrone MV, Buoni S, Fois A (2000) Neuronal ceroid lipofuscinoses: clinical and EEG findings in a large study of Italian cases. Neurol Sci 21:S75–S81CrossRefPubMed Veneselli E, Biancheri R, Perrone MV, Buoni S, Fois A (2000) Neuronal ceroid lipofuscinoses: clinical and EEG findings in a large study of Italian cases. Neurol Sci 21:S75–S81CrossRefPubMed
157.
go back to reference Iannetti P, Messa C, Spalice A, Lucignani G, Fazio F (1994) Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky–Bielschowsky disease): a case report. Brain Dev 16:459–462CrossRefPubMed Iannetti P, Messa C, Spalice A, Lucignani G, Fazio F (1994) Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky–Bielschowsky disease): a case report. Brain Dev 16:459–462CrossRefPubMed
158.
go back to reference Williams RE, Lake BD, Elleder M, Sharp J (1999) CLN6—variant late infantile/early juvenile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 102–113 Williams RE, Lake BD, Elleder M, Sharp J (1999) CLN6—variant late infantile/early juvenile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 102–113
159.
go back to reference Heine C, Tyynela J, Cooper JD, Palmer DN, Elleder M, Kohlschutter A, Braulke T (2003) Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues. Biochem J 376:369–376CrossRefPubMed Heine C, Tyynela J, Cooper JD, Palmer DN, Elleder M, Kohlschutter A, Braulke T (2003) Enhanced expression of manganese-dependent superoxide dismutase in human and sheep CLN6 tissues. Biochem J 376:369–376CrossRefPubMed
160.
go back to reference Mitchell WA, Wheeler RB, Sharp JD, Bate SL, Gardiner RM, Ranta US, Lonka L, Williams RE, Lehesjoki AE, Mole SE (2001) Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8. Eur J Paediatr Neurol 5(Suppl A):21–27CrossRefPubMed Mitchell WA, Wheeler RB, Sharp JD, Bate SL, Gardiner RM, Ranta US, Lonka L, Williams RE, Lehesjoki AE, Mole SE (2001) Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8. Eur J Paediatr Neurol 5(Suppl A):21–27CrossRefPubMed
161.
go back to reference Ranta S, Topçu M, Tegelberg S, Tan H, Üstübütün A, Saatci I, Dufke A, Enders H, Pohl K, Alembik Y, Mitchell WA, Mole SE, Lehesjoki A-E (2004) Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 23:300–305CrossRefPubMed Ranta S, Topçu M, Tegelberg S, Tan H, Üstübütün A, Saatci I, Dufke A, Enders H, Pohl K, Alembik Y, Mitchell WA, Mole SE, Lehesjoki A-E (2004) Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 23:300–305CrossRefPubMed
162.
go back to reference Williams RE, Topçu M, Lake BD, Mitchell WA, Mole SE (1999) CLN7—Turkish variant late infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 114–116 Williams RE, Topçu M, Lake BD, Mitchell WA, Mole SE (1999) CLN7—Turkish variant late infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 114–116
163.
go back to reference Ranta S, Zhang Y, Ross B, Lonka L, Takkunen E, Messer A, Sharp J, Wheeler R, Kusumi K, Mole S, Liu W, Soares MB, de Fatima Bonaldo M, Hirvasniemi A, de la Chapelle A, Gilliam TC, Lehesjoki AE (1999) The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 23:233–236CrossRefPubMed Ranta S, Zhang Y, Ross B, Lonka L, Takkunen E, Messer A, Sharp J, Wheeler R, Kusumi K, Mole S, Liu W, Soares MB, de Fatima Bonaldo M, Hirvasniemi A, de la Chapelle A, Gilliam TC, Lehesjoki AE (1999) The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 23:233–236CrossRefPubMed
164.
go back to reference Lonka L, Kyttälä A, Ranta S, Jalanko A, Lehesjoki AE (2000) The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum Mol Genet 9:1691–1697CrossRefPubMed Lonka L, Kyttälä A, Ranta S, Jalanko A, Lehesjoki AE (2000) The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum Mol Genet 9:1691–1697CrossRefPubMed
165.
go back to reference Lonka L, Salonen T, Siintola E, Kopra O, Lehesjoki AE, Jalanko A (2004) Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells. J Neurosci Res 76:862–871CrossRefPubMed Lonka L, Salonen T, Siintola E, Kopra O, Lehesjoki AE, Jalanko A (2004) Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells. J Neurosci Res 76:862–871CrossRefPubMed
166.
go back to reference Winter E, Ponting CP (2002) TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains? Trends Biochem Sci 27:381–383CrossRefPubMed Winter E, Ponting CP (2002) TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains? Trends Biochem Sci 27:381–383CrossRefPubMed
167.
go back to reference Katz ML, Khan S, Awano T, Shahid SA, Siakotos AN, Johnson GS (2005) A mutation in the CLN8 gene in English setter dogs with neuronal ceroid-lipofuscinosis. Biochem Biophys Res Commun 327:541–547CrossRefPubMed Katz ML, Khan S, Awano T, Shahid SA, Siakotos AN, Johnson GS (2005) A mutation in the CLN8 gene in English setter dogs with neuronal ceroid-lipofuscinosis. Biochem Biophys Res Commun 327:541–547CrossRefPubMed
168.
go back to reference Hirvasniemi A, Lang H, Lehesjoki AE, Leisti J (1994) Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet 31:177–182PubMed Hirvasniemi A, Lang H, Lehesjoki AE, Leisti J (1994) Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet 31:177–182PubMed
169.
go back to reference Topçu M, Tan H, Yalnizoglu D, Usubutun A, Saatci I, Aynaci M, Anlar B, Topaloglu H, Turanli G, Kose G, Aysun S (2004) Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr 46:1–10PubMed Topçu M, Tan H, Yalnizoglu D, Usubutun A, Saatci I, Aynaci M, Anlar B, Topaloglu H, Turanli G, Kose G, Aysun S (2004) Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr 46:1–10PubMed
170.
go back to reference Herva R, Tyynela J, Hirvasniemi A, Syrjakallio-Ylitalo M, Haltia M (2000) Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis. Brain Pathol 10:215–222PubMedCrossRef Herva R, Tyynela J, Hirvasniemi A, Syrjakallio-Ylitalo M, Haltia M (2000) Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis. Brain Pathol 10:215–222PubMedCrossRef
171.
go back to reference Haltia M, Tyynelä J, Hirvasniemi A, Herva R, Ranta US, Lehesjoki A-E (1999) CLN8—Northern epilepsy. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 117–124 Haltia M, Tyynelä J, Hirvasniemi A, Herva R, Ranta US, Lehesjoki A-E (1999) CLN8—Northern epilepsy. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (Batten disease). IOS, Amsterdam, pp 117–124
172.
go back to reference Stengel OC (1826) Account of a singular illness among four siblings in the vicinity of RØraas. Ceroid-lipofuscinosis (Batten’s disease). Elsevier/North Holland Biomedical Press, 1982, Amsterdam, pp 17–19 Stengel OC (1826) Account of a singular illness among four siblings in the vicinity of RØraas. Ceroid-lipofuscinosis (Batten’s disease). Elsevier/North Holland Biomedical Press, 1982, Amsterdam, pp 17–19
173.
go back to reference Zeman W, Dyken P (1969) Neuronal ceroid-lipofuscinosis (Batten’s disease): relationship to amaurotic familial idiocy? Pediatrics 44:570–583PubMed Zeman W, Dyken P (1969) Neuronal ceroid-lipofuscinosis (Batten’s disease): relationship to amaurotic familial idiocy? Pediatrics 44:570–583PubMed
174.
go back to reference Zeman W (1971) Morphological approaches to the nosology of nervous system defects. Birth Defects Orig Artic Ser 3:23–30 Zeman W (1971) Morphological approaches to the nosology of nervous system defects. Birth Defects Orig Artic Ser 3:23–30
175.
go back to reference Tyynelä J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, Haltia M, Lobel P (2000) A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 19:2786–2792CrossRefPubMed Tyynelä J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, Haltia M, Lobel P (2000) A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 19:2786–2792CrossRefPubMed
176.
go back to reference Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y, Schulz-Schaeffer W, Watanabe T, Waguri S, Kametaka S, Shibata M, Yamamoto K, Kominami E, Peters C, von Figura K, Uchiyama Y (2000) Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20:6898–6906PubMed Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y, Schulz-Schaeffer W, Watanabe T, Waguri S, Kametaka S, Shibata M, Yamamoto K, Kominami E, Peters C, von Figura K, Uchiyama Y (2000) Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20:6898–6906PubMed
177.
go back to reference Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA, Hammer RE, Hofmann SL (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A 98:13566–13571CrossRefPubMed Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA, Hammer RE, Hofmann SL (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A 98:13566–13571CrossRefPubMed
178.
go back to reference Gupta P, Soyombo AA, Shelton JM, Wilkofsky IG, Wisniewski KE, Richardson JA, Hofmann SL (2003) Disruption of PPT2 in mice causes an unusual lysosomal storage disorder with neurovisceral features. Proc Natl Acad Sci U S A 100:12325–12330CrossRefPubMed Gupta P, Soyombo AA, Shelton JM, Wilkofsky IG, Wisniewski KE, Richardson JA, Hofmann SL (2003) Disruption of PPT2 in mice causes an unusual lysosomal storage disorder with neurovisceral features. Proc Natl Acad Sci U S A 100:12325–12330CrossRefPubMed
179.
go back to reference Jolly RD, Martinus RD, Palmer DN (1992) Sheep and other animals with ceroid lipofuscinoses: their relevance to Batten disease. Am J Med Genet 42:609–614CrossRefPubMed Jolly RD, Martinus RD, Palmer DN (1992) Sheep and other animals with ceroid lipofuscinoses: their relevance to Batten disease. Am J Med Genet 42:609–614CrossRefPubMed
180.
go back to reference Lingaas F, Aarskaug T, Sletten M, Bjerkas I, Grimholt U, Moe L, Juneja RK, Wilton AN, Galibert F, Holmes NG, Dolf G (1998) Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs. Anim Genet 29:371–376CrossRefPubMed Lingaas F, Aarskaug T, Sletten M, Bjerkas I, Grimholt U, Moe L, Juneja RK, Wilton AN, Galibert F, Holmes NG, Dolf G (1998) Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs. Anim Genet 29:371–376CrossRefPubMed
Metadata
Title
Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses
Authors
Sara E. Mole
Ruth E. Williams
Hans H. Goebel
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Neurogenetics / Issue 3/2005
Print ISSN: 1364-6745
Electronic ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-005-0218-3

Other articles of this Issue 3/2005

neurogenetics 3/2005 Go to the issue